D. Boral Capital Has Lowered Expectations for Immunic (NASDAQ:IMUX) Stock Price
Immunic (NASDAQ:IMUX – Get Free Report) had its price objective decreased by equities research analysts at D. Boral Capital from $17.00 to $10.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. A number of other research firms have also weighed in on IMUX. William […]
Immunic (NASDAQ:IMUX – Get Free Report) had its price objective decreased by equities research analysts at D. Boral Capital from $17.00 to $10.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. A number of other research firms have also weighed in on IMUX. William […]
